Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Jul;6(4):607-20.
doi: 10.1586/eci.10.45.

Current status of monoclonal antibody therapy for the treatment of inflammatory bowel disease

Brijen Shah  1 , Lloyd Mayer
Affiliations
Review

Current status of monoclonal antibody therapy for the treatment of inflammatory bowel disease

Brijen Shah et al. Expert Rev Clin Immunol. 2010 Jul.

Abstract

Crohn's disease and ulcerative colitis are complex diseases that have required the use of multiple modalities to aid in treatment. With an increasing understanding of the underlying pathogenetic mechanisms and identification of specific therapeutic targets, monoclonal antibody treatment has been an ideal strategy for inducing and maintaining remission in these patients. This article addresses approved agents and the supporting data justifying their use in Crohn's disease and ulcerative colitis, the safety of and immunologic reactions to these agents, as well as newer agents for treatment.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Loftus EV, Sandborn WJ. Epidemiology of inflammatory bowel disease. Gastroenterol Clin North Am. 2002;31(1):1–20. - PubMed

    1. Abraham C, Cho J. Inflammatory bowel disease. N Engl J Med. 2009;361(21):2066–2078.. • Current review on the pathogenesis of inflammatory bowel disease (IBD)

    1. Van Deventer SJ. Tumor necrosis factor and Crohn’s disease. Gut. 1997;40(4):443–448. - PMC - PubMed
    1. Rescigno M, Urbano M, Wazasina B, et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol. 2001;2(4):361–367. - PubMed
    1. Niess JH, Brand S, Gu X, et al. CX3–CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science. 2005;307(5707):254–258. - PubMed

Publication types